AI Tools Biotech Researchers Are Actually Using Right Now

By Joel Comm | A Trusted Voice in a Noisy Tech World

As a New York Times bestselling author who’s spent 45 years navigating technology disruption, I’ve watched countless innovations follow the Disruption Confidence Cycle from skepticism to adoption. Biotech researchers today aren’t waiting for AI to mature—they’re already integrating practical tools into their daily workflows. The gap between AI hype and biotech reality is closing faster than most realize.

The biotech world has used computational tools for decades. But generative AI is a different animal — it puts powerful capabilities in the hands of every researcher, not just the bioinformatics team. Here are the tools that are actually getting used in labs and offices right now.

The Tools That Are Actually Working

Forget the press releases and product launches. The AI tools worth talking about are the ones Biotech Professionals are quietly using to get more done in less time.

Here are the use cases that matter:

AI-powered research abstract translation that converts dense scientific papers into accessible summaries for different audiences
AI-assisted grant writing that generates first drafts of specific aims and background sections from research notes
AI tools that monitor published literature and patent filings to flag competitive threats and collaboration opportunities
AI-generated investor updates that translate lab results into business milestone language

Why Most Biotech Professionals Haven't Started Yet

It's not because they're behind. It's because the noise-to-signal ratio in AI is terrible right now. Every vendor promises transformation. Most deliver a chatbot.

The professionals who are getting results started small. They picked one workflow that was eating their time, found a tool that handled it, and moved on to the next one. No strategy deck. No committee. Just one problem, one tool, one result.

What to Try First

If you're in Biotech and haven't started with AI yet, pick the task you hate most. The one that's repetitive, time-consuming, and doesn't actually require your expertise. That's where AI earns its keep.

The tools are simpler than you think. The barrier isn't technology — it's the assumption that you need to understand the technology before you can use it. You don't.

The Bigger Picture

Biotech companies are racing to bring therapies to market faster, and AI promises to accelerate everything from target identification to clinical design — but most teams don't know how to separate genuine AI breakthroughs from vendor hype, and the cost of betting wrong is measured in years and billions.

The professionals who figure out AI first don't just save time. They change what their time is worth. That's the pattern Joel covers in his AI Tools keynote — finding the tools that actually move the needle for your team.